Return to List

Study Summary
No. RTOG-0022:.............Adam Garden......Radiation Oncology
.
Study Summary Title
Study Summary
Number:
RTOG-0022
Study Title:Phase I/II Study of Conformal and Intensity Modulated Irradiation for Oropharyngeal Cancer
.
Physician New Patient Referral
Name:Adam GardenPatients Call:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Dept:Radiation OncologyReferring MD
Call:
800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Phone:713-792-3431
Contact us about clinical trials
.
General Information
Disease Group:Supported By:N/A
Phase of Study:Phase I/Phase IIReturn
Visit:
At one and 3 months and 6 months following treatment. then every 6 months for
2.5 years.
Treatment
Agents:
Home Care:Not Applicable
Treatment Loc:Independent Multicenter Arrangements
Estimated
Length of Stay
in Houston:
Not Applicable
Description/
Intervention:
The goal of this clinical research study is to learn if the use of advanced
radiation therapy delivery techniques can spare normal tissue, including
salivary glands, from radiation damage in patients with head and neck cancer.
All side effects, both short term and long term, will also be studied.
.
Study Objectives / Outcomes
To assess the feasibility of adequate target coverage and major salivary gland sparing in patients with oropharyngeal cancer treated with IMRT techniques.

To determine the rate and pattern of locoregional tumor recurrence.

To determine the nature and prevalence of acute and late side effects (using RTOG scales) and their relationship to local dose
.
Study Status Information
Study Activation / Registration Date:
IRB Review and Approval Date:12/04/2001
Study Type:
Recruitment Status:Closed
Projected Accrual:40 participants
.
Enrollment Eligibility
If you do not meet the enrollment eligibility, there may be other treatment options for you. Please Contact the Referral Office for more information.

Inclusion Criteria:Unavailable

Exclusion Criteria:Unavailable

.
Links
Registration Number: NCT00006360
Study Information on Clinical Trials Registry (clinicaltrials.gov)

Other Links:
.
Results


Return to Clinical Trials at M.D. Anderson Cancer Center